Swiss Pharm

Swiss Pharm Co., Ltd. is a prominent Taiwan-based pharmaceutical company founded in 1965 that specializes in the manufacturing and distribution of generic medicines and health supplements. The company operates advanced manufacturing facilities that adhere to international PIC/S GMP standards, ensuring high-quality production for both domestic and international markets. Its extensive product portfolio includes treatments for cardiovascular diseases, gastrointestinal disorders, central nervous system conditions, and metabolic syndromes. Beyond its own product lines, Swiss Pharm serves as a contract development and manufacturing organization (CDMO) for various global pharmaceutical partners. The company is publicly listed on the Taiwan Stock Exchange and continues to expand its footprint in the healthcare sector through research and development of value-added generics.